Reaction to new "News Release"Anyone see the just released report from gagnon.
CZO is getting well ahead of the game and planning for clinic trials of their avenanthramides at the Montreal Heart institue. CZO avenanthramides have proven to be effect in containing heart swelling due to the COVID Virus.
In order to prepare for the clinic trials and subsquent human trials, gagnon is working closely with his production group and scientist to ensure that sufficient quantity and quality of the avenanthramides if available. gagnon is quoted to saying "Considering the timeline it will be difficult to achieve but we are hopeful". The trial date is slated to occur during the next pandemics which historically will be 100 years form now, give or take 10 years.
gagnon also mentioned that GILLE GAGNON 3rd will be CEO and will heading the trial.
Ronnie Miller was to add further comments but failed to show up for the Press Release.